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biological processes and is particularly well illustrated
by the mechanisms of gene regulation. Analysis of
these mechanisms reveals that regulated localization
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Introduction
Two broad classes of enzymes are distinguished by their
modes of regulation. Members of the first class, exempli-
fied by the enzymes of intermediary metabolism, recog-
nize one or a few specific substrates, and are regulated by
substrate concentration and by allosteric effects exerted by
other small molecules. In contrast, members of the second
class can recognize a large array of related substrates, the
concentrations of which do not vary. This class includes,
for example, RNA polymerase, protein sorting and degrad-
ing enzymes, and the kinases and phosphatases of signal
transduction pathways.
We shall discuss a common and widely used strategy by
which enzymes in this second class are regulated; how, for
example, one extracellular signal leads to one pattern of
gene expression or protein phosphorylation, whereas
another directs the same enzymatic machinery to produce
a different pattern. As a great deal of recent work has
revealed, this strategy entails the regulated localization of
the enzyme with the appropriate substrate. Thus, in
response to one signal, an enzyme is directed to one sub-
strate on which it then acts spontaneously; in response to a
different signal, it is directed to, and works on, a different
substrate. The term localization is used here in the sense of
‘apposition’, and does not necessarily imply sequestration
to particular sites or compartments within the cell.
We shall argue that gene regulation presents a particularly
well-characterized example of the localization strategy. In
this case, localization is often effected by ‘locator’ proteins
— transcriptional activators — that bring the enzyme,
RNA polymerase, to specified genes (or more precisely to
specific promoter sequences found there). Specificity can
be, and typically is, imposed by simple binding interac-
tions between a locator, the transcriptional machinery and
the DNA. We suggest that much of the complexity of gene
regulatory systems has been acquired by the accretion of
evolutionary ‘add-ons’ to this basic mechanism, a scenario
that accounts, at least in part, for the nature of that com-
plexity. The system is highly ‘evolvable’ [1,2]: new pat-
terns of gene expression are readily generated, often using
new combinations of existing activators. After discussing
these matters as they apply to gene regulation, we consider
a few examples from signal transduction that illustrate com-
mon strategies for imposing specificity in these disparate
systems (for related discussions see [3–6]). 
Cooperative binding of proteins to DNA
Much of gene regulation depends upon the cooperative
binding of proteins to DNA. Cooperative binding is used
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to direct proteins to specific sites on DNA — that is, to
properly locate them — and Figure 1 shows a simple
example. As is typical of a DNA-binding protein, the
depicted protein recognizes related sequences with differ-
ent affinities. At its cellular concentration, the protein
spontaneously binds to certain sites (‘strong’ sites) but
leaves others (‘weak’ sites) unfilled. The protein can be
directed to — located at — a weak site by interacting with
a second protein binding simultaneously at a nearby DNA
site. The second protein has located the first at a specific
weak site by increasing the local concentration of the first
protein in the vicinity of that site.
Effective use of cooperative binding requires that the
concentration of interacting proteins be controlled. This
requirement arises because, usually, rather weak interac-
tions between pairs of cooperatively binding proteins —
interaction energies on the order of one or a few kilo-
calories — dictate the reaction. Simply raising the concen-
tration of a protein — as little as ten-fold — often suffices,
therefore, to promote spontaneous binding to weak sites.
Consequently, if cooperative binding is the way of regulat-
ing localization, the interacting proteins must be main-
tained below levels at which their interactions become
unnecessary for binding.
In the simplest scenario, neither partner of a pair of co-
operatively binding proteins needs to undergo a modification
or a conformational change; rather, the interaction between
the proteins, as well as that between the proteins and DNA,
need only provide binding energy. Therefore, these kinds of
interactions — which can of course be highly specific —
need only be adhesive (glue- or velcro-like).
Activators as locators
Escherichia coli RNA polymerase illustrates several of these
general features of DNA-binding proteins (Figure 2). At
the concentration of polymerase found in the bacterium
certain promoters constitute ‘strong’ sites and are therefore
recognized spontaneously at high frequency, whereas oth-
ers are ‘weak’, and are recognized only infrequently.
Genes with either category of promoter, however, can be
regulated using the principles described above so as to pro-
duce equally high (or low) levels of transcription, and to do
so only when appropriate. For example, RNA polymerase
can be directed to a specific weak promoter, and the gene
thereby activated, by binding cooperatively to DNA with
another protein, called an activator.
The typical activator bears two essential surfaces: one that
recognizes a specific site on DNA, and another, the ‘acti-
vating region’, that interacts with RNA polymerase. In this
scenario, the specificity of the reaction — which promoter
is chosen — is dictated by specific binding of the activator
to a site near one (or another) promoter. From our present
Figure 1
Localization by cooperative binding to DNA. Protein A binds to the
strong (s) site on DNA molecule 1, but not to the weak (w) site on
molecule 2. Protein A does, however, bind to the weak site on mole-
cule 3 by virtue of an interaction with, and hence cooperative binding
with, another protein that binds to a site nearby. At the appropriate
concentrations and affinities, the ‘helping’ protein could be another
molecule of protein A binding to a second binding site. Another way
to have protein A fill the weak sites on molecules 2 and 3 would be to
raise the concentration of the protein, in which case no cooperativity
would be needed. Note that the two sites on molecule 3 are separat-
ed by an unspecified number of base pairs, and the DNA has formed
















Gene activation as an example of cooperative binding to DNA. The
promoter sequence of gene 1 binds polymerase sufficiently tightly that
the gene is ‘on’ in the absence of any activator (and of any repressor
that would otherwise prevent polymerase binding). Genes 2 and 3
have weak promoters, and polymerase binds only if helped to do so
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perspective, as mentioned in the introduction, activators
would appropriately be called ‘locators’. We have reviewed
elsewhere [7] the various strands of evidence demonstrat-
ing that many (but not all) genes, in both prokaryotes and
eukaryotes, are designed so that they can be regulated by
localization (see Box 1).
The simple scheme for gene activation illustrated in
Figure 2 readily lends itself to modulation by further coop-
erative binding. For example, in many instances the acti-
vator itself interacts, and binds cooperatively to DNA,
with other proteins. Those additional proteins may or may
not be activators themselves, but in either case the result
is to make the effect of any given activator dependent
upon cooperative binding with other proteins. As we shall
see, these kinds of auxiliary interactions can be used to
make activation of a given gene dependent upon more
than one physiological signal, and to make sensitive
switches. There is a further source of cooperativity implic-
it in this scheme, one that makes it easy to see how 
activators that do not interact with each other can never-
theless work synergistically. Any DNA-bound activators
that can simultaneously touch the transcriptional machin-
ery would work synergistically, because each would con-
tribute binding energy to the recruitment reaction. The
observations of unrelated activators working synergistical-
ly when placed near a gene are consistent with this expec-
tation, and they suggest facile evolutionary pathways for
modifying the regulation of genes.
Other proteins, called repressors, prevent access to the pro-
moter and turn off transcription. Many genes are con-
trolled by a combination of repressors and activators. This
strategy plausibly follows from the notion that activators
merely increase the local concentration of polymerase at a
promoter, and so in their absence there will inevitably be a
basal level of transcription at a rate that will vary depend-
ing on the strength of the promoter. So where genes are
controlled by activators of the sort we are describing, they
are often maintained in the off state by repressors in the
Gene activation: a changed perspective
Our license to describe gene activation as a process of RNA
polymerase localization, or recruitment [7], depends upon a series of
developments that, over the past few years, have ‘uncomplicated’
our view of the process. We reviewed these matters recently [7],
and here outline a few of these developments (references are given
only for papers that appeared since publication of [7]). 
As of a few years ago, at least three apparent problems
confounded attempts to formulate a unified model of gene activation.
First, in eukaryotes, transcription initiation seemed to require the
multi-step assembly of a complicated machine, and activators were
imagined to affect various steps in this process; this would be in
striking contrast to bacteria, where we find a preassembled RNA
polymerase molecule. Second, the requirement for specific additional
proteins for activators to work in vitro raised the possibility that such
proteins acted as ‘signal transducers’, converting the machinery into
an activated form by an allosteric transition. This would again contrast
strikingly with the situation in bacteria. Third, the bacterial regulatory
proteins lambda repressor and E. coli catabolite activator protein
(CAP) appeared to affect kinetically distinguishable steps in
transcription initiation, raising the possibility that even these bacterial
activators can work by different mechanisms that require different
kinds of activator-polymerase interactions.
These conceptual difficulties appear much less formidable now
because of a number of developments. First, it was found that, in
yeast, although the transcriptional machinery may be even larger
than previously imagined, many of the proteins occur in the cell in
large complexes, possibly just one large complex. Complications
remain of course: there may be different forms of these complexes,
more than one recruiting event may be required, and the specific
requirements may differ at different genes (see [28,29]), but the
emerging picture much more closely resembles the situation in
bacteria than did the previous scenario. 
Two different kinds of experiment argue against the notion that
activators allosterically modify polymerase. First, the so-called
‘activator bypass’ experiments show that bacterial and eukaryotic
genes can both be activated in the absence of any typical (classical)
activator. For example, a a DNA-binding domain fused to a
component of the transcriptional machinery can activate
transcription very efficiently at promoters bearing the appropriate
DNA-binding site, in either bacteria or yeast, as can an arbitrary
contact between a DNA-tethered peptide and the machinery. And
simply increasing the concentration of the bacterial or yeast
transcriptional machinery in vitro suffices to mimic the effects of
activators. Second, a variety of experiments, both in vivo and in vitro,
show eukaryotic genes can be activated by typical activators in the
absence of certain proteins that had previously been described as
specifically required for activation ([30–32]; see also [33]).
Finally, despite the apparent differences between the ordinary
actions of CAP and lambda repressor mentioned above, it is not
necessary to postulate that they contact polymerase in importantly
different ways. For example, activator bypass experiments show that
arbitrary interactions between a DNA-tethered peptide and
polymerase activate transcription at the two promoters ordinarily
activated by lambda repressor and CAP, respectively, and that CAP
can efficiently activate transcription when artificially positioned at the
promoter normally activated by lambda. For these and other reasons,
it now seems likely that, despite the kinetic differences noted above,
CAP and lambda repressor both activate transcription by simple
adhesive or glue-like interactions with polymerase. Because of this,
and because the essential effect of these activators is to stabilize
the polymerase at the promoter, we refer in the text to the process
interchangeably as recruitment/cooperative binding. (For a fuller
discussion see [7].)
In bacteria a typical activator, such as lambda repressor or
CAP, touches one or two specific sites on polymerase. But many
sites are potential targets for different activators and it is not
difficult to create, by mutation, new interactions that mediate
activation. In eukaryotes, the typical activating region evidently
contacts any of several, perhaps many, sites on the transcriptional
machinery. When tethered to DNA, many vaguely related peptides
(reminiscent in this regard of sorting signals on proteins) can
function as activating regions. We know of one case in bacteria in
which recruitment does not suffice for activation. In that case the
activator (NTRC) presumably contacts a unique site on polymerase
(which bears a special sigma subunit) and, in an energy-dependent
process, induces a conformational change that triggers
transcription (see [7]).
Box 1
absence of those activators. In eukaryotes, nucleosomes
would be expected to contribute to this effect (see Box 2). 
Allostery — the rest of the story
Extracellular signals that regulate genes are not generally
detected by the simple binding interactions of the sort we
have been describing; rather, each such signal is often
accompanied by an allosteric change in a target protein.
For example, the Lac repressor of E. coli undergoes a struc-
tural transition, upon binding to a metabolic derivative of
lactose, that prevents it from binding DNA [8]. This and
many other examples suggest a generalization: allosteric-
like interactions are typically used to reveal the presence
of an extracellular signal, but the specific interpretation of
that signal is then dictated by the localization mechanisms
we have discussed. Moreover, the meaning of any given
signal can be changed or expanded without changing the
allosteric response itself. For example, Lac repressor
detects the presence of lactose, but that condition can be
used to repress any gene depending upon the disposition
of the repressor binding sites on DNA.
Examples of gene regulation in bacteria
We shall consider the action of two well-studied bacterial
transcriptional activators: catabolite activator protein
(CAP) and lambda repressor (despite its name). The abili-
ty of each to bind DNA, and hence to work, is determined
by extracellular signals that induce changes in the proteins:
CAP functions only in the absence of glucose [9,10], and
lambda repressor is inactivated when DNA is damaged by
agents such as ultraviolet light [11]. The specificity of
action of each protein — which gene it regulates — is
determined by its DNA-binding address. CAP ordinarily
binds to sites near, and activates, genes encoding enzymes
required for metabolism of various sugars, and lambda
repressor ordinarily activates its own gene [11]. If a CAP
site is introduced upstream of the promoter of the lambda
repressor gene, in the absence of glucose CAP will activate
that gene [12]. The meaning of the physiological signal —
in this case the absence of glucose — can thus be ‘reinter-
preted’ simply by introducing the relevant DNA site in
front of a gene.
The activities of CAP and lambda repressor illustrate two
additional features expected of locators that work as out-
lined above. First, if both CAP and lambda repressor are
positioned adjacent to a promoter so that each can make its
natural contact with polymerase, the two activators work
synergistically, as expected if the proteins simultaneously
contact polymerase and, adding those energies of interac-
tion, work together to recruit polymerase [12]. Second,
each protein can, and at certain promoters does (as one of
the names suggests) work as a repressor; all that is required
is that the protein be positioned so that, rather than mak-
ing a fruitful contact with polymerase, it blocks polymerase
binding [10,11].
Sugar metabolism genes in E. coli: multiple signals and
combinatorial control
This case shows one way that regulators that do no more
than help or hinder polymerase localization can make
expression of a gene dependent on two signals, and it also
illustrates how regulators can be used in different combi-
nations. E. coli bears separate sets of genes, each of which
encodes enzymes that direct metabolism of one or another
of a wide array of sugars. The biological problem is to
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Chromatin and gene regulation
To some extent there have been two cultures studying the problem
of eukaryotic gene regulation: one focused on the properties of
nucleosomal DNA (chromatin), and the other, inspired by the
bacterial paradigms, studied the actions of specific regulatory
proteins without regard for chromatin structure. The main theme of
this article brings these two approaches into congruence. Thus, the
idea that activation merely involves locating the transcription
machinery at the gene implies that any factors that inhibit or facilitate
that relocation process can have an effect on gene expression. In
principle, for example, simply removing histones would suffice to
activate a gene whose promoter had a high affinity for the eukaryotic
transcription machinery, similar to the high affinity of E. coli RNA
polymerase for strong bacterial promoters. 
Two recent experiments have examined the effect of depletion, in
yeast, of histone H4 on expression of a variety of genes. In one case,
amongst a wide array of genes assayed, 70% were unaffected; of
the remainder, some showed increased and some decreased
transcription (R. Young, personal communication). In the other case,
there was no detectable increase in transcription of the genes
CUP1, GAL1 or ADH1; a modest (few-fold) increase in transcription
from several heat-shock genes was observed, but the level of
transcription reached was far below that elicited by the physiological
activator of these genes (M. Green, personal communication). These
studies indicate that for many, perhaps all, genes, histone removal
does not suffice to achieve full activation, but they do not argue
against the idea that histone modification or removal might help
activators work.
Recent experiments show that histones are subject to a number
of modifications — acetylation, phosphorylation, ubiquitination — any
of which might affect transcription by modulating the accessibility of
DNA to regulatory proteins and the transcription machinery [34].
Thus, for example, Gcn5, a protein that facilitates activation of a set
of genes in yeast, encodes an acetylase that can act on histones,
and its removal decreases activation of a few genes. It is suggested
that acetylation ‘loosens’ the histones and thereby facilitates access.
Similarly, a deacetylase, targeted to a gene in yeast, can have an
inhibitory effect. A variety of other protein complexes have been
described in yeast and higher eukaryotes that may modify the
configuration of nucleosomes [35,36]. It would seem, a priori, that
there are three ways that these complexes might work: they might
be incorporated as part of the transcription machinery brought to the
promoter by the activators; they might be brought separately to the
DNA by activators; and/or they might work constitutively as a
background function in cells. Which, if any, of these applies in any
given case is a subject of current investigation.
Box 2
ensure that any given set of such genes is expressed if, and
only if, two conditions hold: first, that the relevant sugar,
such as lactose or galactose, is present in the medium, and
second, that glucose, a better carbon source, is absent.
Figure 3 shows how this is achieved for the lac genes.
These genes are activated by CAP, which as we have
noted is only active in the absence of glucose, but only if
lactose, which inactivates the Lac repressor, is also pre-
sent. Regulators that work as described in Figure 3 readi-
ly lend themselves to being used in different combina-
tions. For example, a CAP site is also located upstream of
the gal genes, where CAP works with the Gal repressor to
control transcription. Thus CAP activates the gal genes in
the absence of glucose, provided that galactose is simulta-
neously present to inactivate the Gal repressor. CAP works
in combination with many other regulators at some 100
genes in E. coli [10].
It is not difficult to imagine how systems such as this
evolved by ‘tinkering’ [13] with a rudimentary system that
worked but was inefficient. Thus, for example, in the
absence of binding sites for the regulatory proteins, the
weak lac promoter would be read at a constant and low
level. The bacterium would be able to use lactose, but it
would make the enzymes even when there was no lactose
substrate and also when the superior carbon source glucose
was present. The first improvement would be addition of
a CAP-binding site, positioned so that CAP would contact
polymerase at the promoter and hence bind cooperatively
to DNA with it. This would not be difficult because,
evidently, many of a wide range of activator–polymerase
contacts suffice for activation (see Box 1). The system
would now provide high levels of the enzyme in the
absence of glucose, and lower levels in its presence, with-
out regard to the presence of lactose. A further refinement
would be addition of a binding site for Lac repressor,
which would ensure that transcription is off in the absence
of lactose.
Phage lambda: using simple binding interactions to make
a sensitive switch
The following example shows how simple binding interac-
tions can create a switch that responds in an all-or-none
fashion to an extracellular signal. The biological problem is
that the genes of the bacterial virus lambda within a host E
coli cell must be maintained in a silent state, known as
lysogeny, until an inducing signal is detected, whereupon
they must be efficiently activated, leading to lytic growth
[11]. This regulatory problem has been solved by con-
structing a biphasic switch involving two adjacent promot-
ers that are controlled according to the rule that, when one
is on, the other is off. Here we find two forms of coopera-
tivity in addition to that involving an activator and RNA
polymerase, and these additional features are crucial to the
efficiency of the switch. The details of how the switch
works are explained below and illustrated in Figure 4; it is
not difficult to imagine how this switch might have
evolved by a series of ‘add-ons’, and a possible scenario for
this is detailed in Box 3.
The key regulator is the lambda repressor, a protein that
simultaneously activates transcription of its own gene as it
turns off other genes. As shown in Figure 4, two DNA-
bound repressor dimers are positioned so that they cover
and turn off the strong rightwards promoter, PR, which
controls the lytic genes; simultaneously, one of these
repressors contacts RNA polymerase and activates tran-
scription of the weak leftwards promoter, PRM. This acti-
vation ensures that, once repressor synthesis has been ini-
tiated, an event that requires a separate promoter and acti-
vator, repressor maintains its own synthesis. The phage
genome is thereby stably maintained in a near-silent state,
the only active gene being that of repressor itself. The sys-
tem stably perpetuates itself until the cell encounters the
signal that triggers the switch mechanism. Then, as repres-
sor is inactivated, the rate of further repressor synthesis
also drops. The first gene transcribed upon induction, cro,
encodes a repressor that turns off PRM, thus further ensur-
ing that induction of lytic growth is an ‘all-or-none’ effect. 
The two additional forms of cooperativity in the lambda
switch alluded to above mediate cooperative binding of
the repressor to DNA. Thus, in the cell, repressor
monomers are in concentration-dependent equilibrium
with dimers, the DNA-binding species, and two repressor
dimers bind cooperatively to the adjacent operator sites, as
R816 Current Biology, Vol 8 No 22
Figure 3
The lac promoter in E. coli. In the absence of any controlling factors,
and at concentrations typically found in the cell, polymerase tran-
scribes the genes at a low level. Transcription is increased some 50-
fold by CAP, which binds just upstream of the polymerase and, by
simultaneously contacting polymerase with its ‘activating region’, binds
cooperatively with it. The Lac repressor (Rep) has the opposite effect:
it binds to a site in the promoter that overlaps sequences that other-
wise would be contacted by RNA polymerase and thereby prevents
transcription. CAP and Lac repressor respond to separate physiologi-
cal signals allosterically; CAP binds DNA only when complexed with
cyclic AMP, which is depleted by growth in glucose; and when com-
plexed with a metabolite of lactose, Lac repressor cannot bind DNA.
ON
lac genes
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shown in Figure 4. These repressor–repressor interactions
ensure that the operator sites are filled as a highly sig-
moidal function of the repressor concentration, providing
both a buffer against minor fluctuations in repressor con-
centration and a dramatic change in state when some sig-
nificant but readily obtainable proportion of repressor
(approximately 90%) is inactivated. 
A remarkable feature of the switch is that it depends upon
a series of weak protein–protein interactions. Thus, under
physiological conditions, PRM is only activated by a factor
of about ten, and cooperative binding to the two adjacent
sites also has just a ten-fold effect. Each of these interac-
tions therefore requires only a kilocalorie or two of binding
energy, an amount easily provided by a simple
protein–protein interaction. The requirement for each of
the three protein–protein interactions, analyzed separate-
ly, can be dispensed with simply by increasing the con-
centration of one of the components. For example, increas-
ing the concentration of polymerase in vitro is sufficient to
elicit activated levels of transcription from PRM in the
absence of repressor [14]. Also, although binding of repres-
sor to the site adjacent to polymerase (OR2) ordinarily
depends upon interaction with another repressor dimer
binding to the auxiliary site (OR1), merely increasing the
repressor concentration some ten-fold obviates the need
for this interaction — repressor then binds spontaneously
to OR2 and performs both of the required functions (acti-
vation and repression). Thus, although repressor at OR1
also helps repress PR, its uniquely required function is to
impose cooperativity on the system. 
As illustrated in Figure 4, the three protein–protein inter-
actions seen in the switch — repressor dimerization, coop-
erative binding of repressor dimers, and interaction with
polymerase — involve separate patches on the surface of
repressor. Nevertheless, it is likely that, as expected for a
series of simple binding interactions, they are interchange-
able: for example, the protein–protein interaction between
repressor and polymerase responsible for activation can be
replaced by the one that normally mediates cooperative
binding. This is an example of an ‘activator bypass’ exper-
iment of the kind described in Box 1. In this case, poly-
merase is modified so as to bear a pair of lambda repressor
carboxyl domains; interaction of these carboxyl domains
with those of a lambda repressor bound to DNA nearby
suffices for gene activation. The interaction that ordinarily
mediates cooperative binding of lambda repressors can
thus equally well mediate transcriptional activation [15]. 
The importance of the two repressor–repressor interactions
that promote cooperative DNA binding — repressor dimer-
ization and interaction of repressor dimers – is demonstrat-
ed by the fact that induction works simply by eliminating
these functions. We noted above that ultraviolet irradiation
inactivates repressor; this inactivation is mediated by a
protein, RecA, which recognizes DNA and undergoes an
allosteric transition that activates its protease function.
Repressor is cleaved at a specific site in the peptide
sequence that links the two domains, amino and carboxyl,
of the protein. The amino domain is capable of carrying out
the essential functions of the intact repressor — DNA bind-
ing, and hence repression of one set of genes, and contact
with polymerase, and hence activation of the repressor gene
— but at the concentration found in cells it fails to do so in
the absence of the cooperative effects mediated by the car-
boxyl domain. The sole function of the carboxyl domain is
to promote dimer formation and interaction between
dimers (using separate surfaces); separating the amino from
the carboxyl domain, which eliminates both of these forms
of cooperativity, is sufficient to trigger induction.
And herein lies the problem incurred by relying upon
relatively weak binding interactions to impose specificity
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Figure 4
The phage lambda switch. Repressor monomers, comprising two
domains separated by a linker, are in equilibrium with dimers, the
DNA-binding species. Two repressor dimers bind cooperatively to the
adjacent operator sites OR1 and OR2. Repressor at these two sites
represses the lytic promoter PR, a strong promoter that works at a
high level spontaneously unless repressed; simultaneously, repressor
activates the weak promoter of the repressor gene itself, PRM (by
virtue of a contact between repressor at OR2 and polymerase at PRM).
At higher concentrations repressor also binds to OR3 and turns off
PRM, and thereby negatively regulates repressor synthesis. The three
surfaces on repressor involved in the three examples of cooperativity
— repressor dimerization, interaction between dimers, and interaction
with polymerase to activate PRM — are shaded. As described in the
text, repressor is cleaved in response to ultraviolet radiation, and as a




















by localization: the components must be maintained over a
relatively narrow range of concentration. This is accom-
plished here by the imposition of a third repressor binding
site, OR3, that overlaps PRM; repressor bound to OR3
blocks polymerase binding to PRM and thus negatively reg-
ulates its own synthesis. Repressor binds (cooperatively) to
OR1 and OR2 with an affinity some ten-fold higher than
that with which it binds to OR3, and so OR3 becomes rele-
vant only at higher repressor concentrations. This simple
governing mechanism ensures that repressor never reaches
a concentration at which it can bind to OR2 without dimer-
izing and interacting cooperatively with another repressor
dimer binding to OR1. As might be expected from this line
of analysis, genes encoding many transcriptional regulators
— and indeed those encoding the subunits of RNA 
polymerase — are regulated so as to ensure the concentra-
tions of their products are maintained below specified 
levels (see for example [10,16]).
Gene regulation in eukaryotes
We noted above an experiment in which a bacterial gene
was brought under control of a heterologous activator
(CAP) merely by introducing the binding site for that regu-
lator near the gene. Similar experiments have been per-
formed with many activators and genes in many eukary-
otes; the experiment is actually easier to perform in eukary-
otes, as a successful outcome is much less dependent upon
precise positioning of the activator relative to the gene.
Two factors evidently contribute to this greater flexibility
of the eukaryotic system: a typical eukaryotic activator
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Hypothetical stages in the evolution of the lambda switch
Stage 1. The primitive lambda genome bears two promoters, one for
the lytic genes (PR) and one for the repressor gene (PRM). A single
lambda repressor binding site overlaps PR, and repressor bound at
this site turns off the lytic genes. But bound repressor has no
stimulatory effect on PRM, and so repressor synthesis is unregulated.
If sufficient repressor were made, the lysogen would be stable, but
induction would be inefficient: the repressor gene would continue to
be transcribed at the same rate before and after induction, and the
newly made repressor would impede lytic growth. 
Stage 2. The single repressor-binding site has been moved
close to PRM, so that repressor bound there would contact
polymerase at PRM and thereby stimulate that promoter at the same
time as it represses PR. In the process we might imagine PRM to
have been weakened, so that high levels of repressor synthesis
depend upon that stimulation. As discussed in the text for the lac
case, positioning an activator, in this case lambda repressor, so that
it can activate transcription is not a difficult task. This improvement
facilitates induction because, as repressor is destroyed, its rate of
synthesis drops. Despite this improvement, the switch mechanism
would remain inefficient. Among other problems (see below) the
curve describing the binding of a single protein to a single site on
DNA as a function of repressor concentration bears no steep
inflection. The switch therefore would lack the all-or-none quality that
ensures stable lysogeny in the absence of a signal but efficient
induction upon receipt of the signal.
Stage 3. At this stage, an additional repressor-binding site has
been introduced, so that the system now resembles that of Figure 4,
except that OR3 is missing. A new protein–protein interaction
surface has also been introduced, which mediates cooperative
binding of repressor dimers to the adjacent sites. This additional
cooperativity increases the efficiency of the switch mechanism, as
described in the text, but only if the repressor concentration does
not fluctuate to a higher level at which binding occurs without
cooperativity.
Stage 4. The third repressor-binding site (OR3) has been
introduced, allowing repressor to negatively regulate its own
synthesis. Thus, the repressor concentration never exceeds a
critical level, which helps ensure an efficient switching
mechanism. The final refinement is the introduction of cro, the first
gene transcribed from PR upon induction. Cro protein binds tightly
to OR3 and abolishes repressor synthesis as the lytic cycle
begins. (At a ten-fold higher concentration, Cro also binds to 
OR1 and OR2 and down-regulates its own synthesis later in the
lytic cycle). 
None of the complex elements of the switch we have described is
‘accidental’. We draw this surmise from the fact that lambda is but one
of a group of bacterial viruses, each of which bears the key features we
have just described, although the molecular details differ in each case.
For example, in phage P22, repressor at OR2 touches polymerase at
PRM, but because the positioning of these elements is different from
that found in lambda, a rather different surface of the repressor
contacts polymerase. We do not know whether this represents
convergent or divergent evolution, but it would seem that, despite
differences in molecular detail, the main features of the switch have
been either re-invented or retained in the face of evolutionary pressure.
Box 3































apparently binds more tightly to its targets in the transcrip-
tional machinery than does a typical bacterial activator, and
hence will work from further upstream; and a typical
eukaryotic activating region evidently can contact several,
perhaps many, sites on the transcriptional machinery. The
latter property may be particularly important in allowing an
activator to work at a wide array of promoters. For example
it may be that, depending on the position of the activator on
DNA in relation to the transcriptional start site in any given
case, certain contacts are used in place of others (L.
Gaudreau, J. Nevado, M. Keaveney, Z. Zaman, G. Bryant,
M. Adam, K. Struhl and M.P., unpublished observations).
Eukaryotes have widely exploited combinatorial strategies
to create gene regulatory networks. Many eukaryotic
genes, especially in higher organisms, respond in a switch-
like fashion to multiple signals. That is, the gene is ‘on’ if,
and only if, several physiological signals are detected
simultaneously. The following example shows how the
mechanisms we have been discussing are used to create
such a switch for the human interferon-β gene (Figure 5).
Here we find that three separate activators — NF-κB,
ATF/Jun and IRF3/7 — bind DNA cooperatively to form a
structure called an enhanceosome. Because of the co-
operativity, formation of this complex requires that each of
the activators receives its appropriate physiological signal,
rendering it capable of binding to DNA. Virus infection,
which produces all three signals, thus triggers formation of
the enhanceosome and activates the interferon-β gene
[17,18]. Once the enhanceosome has formed, the activating
regions carried on its various constituents simultaneously
contact the transcriptional machinery and thereby work
synergistically to activate transcription.
Optimal functioning of the β-interferon enhanceosome
requires rather precise spacings between the binding sites
for the components listed above, as well as for certain
auxiliary proteins. Those spacings ensure that the various
components can simultaneously touch one another, DNA
and the transcriptional machinery. The precise positioning
of the enhanceosome with respect to the promoter is not
critical, however, and the enhanceosome functions when
positioned at any of many sites within hundreds of base
pairs of the gene.
Localization in signal transduction
We noted in the introduction that many biological systems
use the principle of imposing specificity by localization.
Here we give a few examples from signal transduction,
each chosen to illustrate one or another aspect encountered
in our discussion of gene regulation.
STATs and Smads
We suggest an analogy between the workings of a receptor,
in the case we shall consider here a cytokine receptor, and
transcriptional activators like CAP. The latter, as we have
seen, detect external signals and interpret them by working
as locators, bringing together an enzyme, RNA polymerase,
with one or another of its potential substrates, the promot-
ers of target genes. In the cytokine system, the receptor
responds to its signal by bringing together an enzyme — a
kinase — with one or another of its potential substrates, the
so-called STAT proteins. As with the activators, the speci-
ficity of the response — which STAT is phosphorylated —
is determined by simple binding interactions and therefore
is readily changed (see [19] and references therein). 
The cytokine system works, in brief, as illustrated in
Figure 6, which shows two different cytokines interacting
with their respective receptors and activating two different
STATS. The first step, receptor recognition, brings
together two receptor chains and triggers phosphorylation
of receptor tyrosine residues. (In this case, detection of the
signal may itself be regarded as a relocation process [4,20].)
This phosphorylation creates a specific STAT-binding
site. The bound (relocated) STAT is apposed to a kinase
(a JAK) which phosphorylates it, thereby activating the
STAT. The activated STAT, now a dimer, moves to the
nucleus and activates specific genes.
The identity of the STAT activated by a given cytokine is
determined by which STAT binds the receptor. That
specificity is readily altered: interchanging STAT-binding
sites between receptors, or receptor-binding sites — so-
called Src homology 2 (SH2) domains — between STATs,
suffices to swap the specificity of the responses. Thus, the
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Figure 5
The human interferon-β enhanceosome. Three transcriptional activators
– NF-κB, ATF/Jun and IRF-3/7 – are activated in response to virus
infection. The mechanism of activation is different for each transcription
factor. Thus, for example, NF-κB is released from a bound inhibitor and
allowed to enter the nucleus, and the DNA-binding function of ATF/Jun
is activated by phosphorylation. These transcriptional activators –
interacting with each other and with auxiliary proteins such as HMG-Y
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specificity of the response to a given cytokine is deter-
mined, not by the inherent specificity of the kinase, but by
the identity of the STAT that is brought into the vicinity
of the specific receptor and its associated kinase.
We encounter a similar theme with signaling by the growth
and differentiation factors of the tumour growth factor β
(TGF-β) family, TGF-β itself and the bone morphogenet-
ic proteins (BMPs) [21]. In these cases, the receptor phos-
phorylates, on serines or threonines, one of a subset of so-
called Smad proteins, the receptor-regulated or R-Smads.
Phosphorylated R-Smad binds the related protein Smad4
to form a complex which moves into the nucleus, where it
regulates gene expression by interacting with specific
DNA-binding proteins. The genes regulated by activation
of a given receptor are determined by the particular Smad
that it phosphorylates. 
Here again, specificity is determined solely by localization.
The TGF-β receptor binds and phosphorylates Smad2 but
not Smad1, whereas the BMP receptor binds and phos-
phorylates Smad1 but not Smad2. In vitro, however, the
kinase associated with either receptor can phosphorylate
both Smads, and in vivo, swapping the Smad-docking sites
between receptors, or the receptor-binding domains
between Smads, switches specificity, just as we saw in the
STAT system. Changing just four residues in the receptor,
or as few as two residues in the Smad, is sufficient to effect
such a switch in specificity [22].
Because specificity is imposed by localization in these
signaling pathways, they are particularly ‘evolvable’. That
is, it is easy to see how the meaning a cell ascribes to a
given cytokine or TGF-β family member can be changed
or expanded by attaching binding sites for the appropriate
STAT or Smad, respectively, to its receptor. New respons-
es can thus be generated without the need to evolve new
enzymatic activities or specificities, a requirement that
would presumably be more taxing. 
Ras
An important aspect of the ‘localization’ idea is that once
the enzyme (RNA polymerase for example) is brought to
the substrate (in this instance, a specific promoter) the
enzymatic activity (transcription) proceeds spontaneously.
Experiments in which RNA polymerase was artificially
brought to the gene (‘activator bypass’ experiments, see
Box 1), with subsequent activity, have been crucial in for-
mulating our ideas. The same experimental approach has
revealed the sufficiency of localization in another signal
transduction pathway, that involving the small GTPase Ras.
Many receptor tyrosine kinases, such as the epidermal
growth factor receptor, exert their effects through the Ras
pathway, a series of interactions between components
widely conserved in eukaryotic evolution. Once again,
phosphorylation of sites on the receptor in response to the
extracellular signal creates a binding site for, and thus
recruits, another protein, in this case Grb2. The ‘adaptor’
protein Grb2 in turn binds and recruits to the membrane
Sos, which then interacts with and activates, by promoting
exchange of GTP for bound GDP, membrane-bound Ras.
Ras in turn recruits and activates Raf, a kinase that initiates
the so-called mitogen-activated protein (MAP) kinase cas-
cade that results finally in activation of various proteins,
including a number of transcription factors.
In an experiment analogous to an ‘activator bypass’
experiment, Sos was artificially tethered to the membrane
(by myristoylation), and Ras was found to be activated as a
result [23]. Thus an important, and perhaps the sole, role
of the upstream components in this pathway is to recruit
Sos to the membrane in response to the appropriate signal,
where it can work on Ras. Once again, simple binding
interactions, in this case involving SH2 and SH3 domains,
are involved. As would be predicted from this result, over-
production of a fragment of Sos, without specific recruit-
ment to the membrane, also activates the Ras pathway,
albeit weakly [24].
Figure 6
STAT activation. Cytokine A activates gene 1 by inducing phosphorylation
of STAT A, whereas cytokine B activates gene 2 by inducing
phosphorylation of STAT B. If the STAT A binding site on the cytokine
A receptor is replaced by a site that binds STAT B, cytokine A
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MAP kinase pathways in yeast
One consequence of using localization to impose
specificity is that the same enzyme can be used in many
different pathways — in the case of RNA polymerase, to
transcribe, in a regulated fashion, many different genes.
This requires that the enzyme work in combination with
many different regulators. In this section we see an exam-
ple where the specificity of a kinase depends upon its
location, which in turn is determined by interactions with
different partners.
In the yeast Saccharomyces cerevisiae, two separate MAP
kinase pathways, one activated by mating pheromones and
the other by changes in osmolarity, use a common kinase,
Ste11. In one case, mating pheromones activate Ste11,
which then phosphorylates Ste7. In contrast, changes in
osmolarity trigger Sho1 to activate Ste11, which in this case
then phosphorylates Pbs2. Despite the shared component,
there is ordinarily no crosstalk between the pathways,
because they are isolated from each other by sequestration
on separate scaffolds: Ste11 binds with Ste7 and other
components of that pathway to the scaffold protein Ste5,
whereas Ste11 binds with Sho1 and other components to
Pbs2, itself a component of that pathway and the scaffold.
Activation of Ste11 can thus have at least two ‘meanings’,
depending upon which other components it is co-localized
with [25]. (For an interesting mutant in which crosstalk
does occur, see [26].)
An alternative world 
Why is the strategy of imposing specificity by localization
found so widely in nature? Consider, for example, control
of transcription. One could imagine a system in which
specificity is determined purely by allosteric control. In
such a system, there would be a separate RNA polymerase
for each promoter, transcription only being triggered upon
integration of the required signals that would together
induce an allosteric transition in the appropriate poly-
merase. Such a system might appear more simple, in some
regards at least, than that which is observed. For example,
there would be no need for locators nor the elaborate use
of cooperativity of the type we have described.
The first difficulty in constructing such a purely allosteric
world would be to design polymerases that would each
integrate the effects of multiple signals. For example, at
the lac promoter the polymerase would have to be active if,
and only if, lactose were present and glucose absent. The
problem would be magnified in higher eukaryotes where,
as we have seen, the presence or absence of multiple sig-
nals is often integrated in the decision as to whether a
given gene is transcribed. Even if these design problems
were solvable (see [27]), it seems likely that it would be
more difficult to use the principle of combinatorial control
in designing new polymerases that responded to new com-
binations of signals. That is, whereas locators, as we have
seen, can readily be used combinatorially, it is difficult to
imagine that allosteric modules (if they existed) could be
used so flexibly. 
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